Lutris Pharma
PrivateLast Round
Early Funding
Jan 28, 2025
Total Funding Raised
$35M
Momentum Score
25 /100
Company Overview
Lutris Pharma is a clinical-stage biopharmaceutical company that develops novel topical therapies to mitigate the side effects of anti-cancer treatments such as EGFR inhibitors and radiation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lutris Pharma Comps
Public and private peers based on sector, stage, and business model.
Lutris Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 28, 2025 | ||||
| Grant | Oct 24, 2022 |
Lutris Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pontifax Venture Capital | Early Funding |
| aMoon | Early Funding |
| Peregrine Ventures | Early Funding |
| Columbus Venture Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Presented data at the ESMO Gastrointestinal Cancers Congress 2025.
- Jul 7, 2025
Phase 2 trial of LUT014 Gel shows significant efficacy for acneiform rash.
Lutris Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lutris Pharma's valuation, stock price, and market status.
